Reported 3,090,068 shares, up 964,148 (45.4%) from the prior quarter.
Reported value 75.1%; share count 45.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 1140000 |
| 2022-03-31 | 801000 |
| 2022-06-30 | 804000 |
| 2022-09-30 | 611000 |
| 2022-12-31 | 1721075 |
| 2023-03-31 | 1599563 |
| 2023-06-30 | 2616776 |
| 2023-09-30 | 2610537 |
| 2023-12-31 | 4674682 |
| 2024-03-31 | 7404586 |
| 2024-06-30 | 9027047 |
| 2024-09-30 | 8254446 |
| 2024-12-31 | 7419482 |
| 2025-03-31 | 4783320 |
| 2025-06-30 | 8374084 |
| 2025-09-30 | 4869889 |
| 2025-12-31 | 11678 |
| 2026-03-31 | 0 |
| 2026-06-30 | 27062 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | New | 85,180 | +85,180 (0.0%) | < 0.01% | $27,062 | 2026-08-14 | |
| Q1 2026 | Reduced | 0 | -28,026 (-100.0%) | 0 | $0 | 2026-05-15 | |
| Q4 2025 | Reduced | 28,026 | -2,335,998 (-98.8%) | < 0.01% | $11,678 | 2026-02-10 | |
| Q3 2025 | Reduced | 2,364,024 | -726,044 (-23.5%) | < 0.01% | $4,869,889 | 2025-11-14 | |
| Q2 2025 | Added | 3,090,068 | +964,148 (45.4%) | < 0.01% | $8,374,084 | 2025-08-14 | |
| Q1 2025 | Added | 2,125,920 | +6,068 (0.3%) | < 0.01% | $4,783,320 | 2025-05-09 | |
| Q4 2024 | Added | 2,119,852 | +111,471 (5.6%) | < 0.01% | $7,419,482 | 2025-02-11 | |
| Q3 2024 | Reduced | 2,008,381 | -499,132 (-19.9%) | < 0.01% | $8,254,446 | 2024-11-14 | |
| Q2 2024 | Added | 2,507,513 | +263,699 (11.8%) | < 0.01% | $9,027,047 | 2024-08-13 | |
| Q1 2024 | Added | 2,243,814 | +220,142 (10.9%) | < 0.01% | $7,404,586 | 2024-05-15 | |
| Q4 2023 | Unchanged | 2,023,672 | 0 (0.0%) | < 0.01% | $4,674,682 | 2024-02-13 | |
| Q3 2023 | Added | 2,023,672 | +41,266 (2.1%) | < 0.01% | $2,610,537 | 2023-11-14 | |
| Q2 2023 | Reduced | 1,982,406 | -280,379 (-12.4%) | < 0.01% | $2,616,776 | 2023-08-15 | |
| Q1 2023 | Reduced | 2,262,785 | -31,981 (-1.4%) | < 0.01% | $1,599,563 | 2023-05-11 | |
| Q4 2022 | Added | 2,294,766 | +1,585,640 (223.6%) | < 0.01% | $1,721,075 | 2023-02-13 | |
| Q3 2022 | Reduced | 709,126 | -8,329 (-1.2%) | < 0.01% | $611,000 | 2022-11-14 | |
| Q2 2022 | Added | 717,455 | +2,270 (0.3%) | < 0.01% | $804,000 | 2022-08-15 | |
| Q1 2022 | Added | 715,185 | +2,822 (0.4%) | < 0.01% | $801,000 | 2022-05-16 | |
| Q4 2021 | New | 712,363 | +712,363 (0.0%) | < 0.01% | $1,140,000 | 2022-02-14 |
Who else reported the position
103 managers reported MEREO BIOPHARMA GROUP PLC ADR for Q2 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Reduced | 17,688,592 | -5,046,529 | 0.02% | $48,112,970 | 6 qtrs |
| Rubric Capital Management LP | Unchanged | 15,307,347 | 0 | 0.63% | $41,482,910 | 19 qtrs |
| Frazier Life Sciences Management L P | Added | 9,440,112 | +1,620,249 | 1.02% | $25,582,704 | 5 qtrs |
| MANGROVE PARTNERS | Unchanged | 8,636,485 | 0 | 2.51% | $23,404,874 | 9 qtrs |
| DEERFIELD MANAGEMENT COMPANY L P SERIES C | Unchanged | 6,710,429 | 0 | 0.33% | $18,185,263 | 5 qtrs |
| ALKEON CAPITAL MANAGEMENT LLC | Unchanged | 4,698,100 | 0 | 0.02% | $12,731,851 | 19 qtrs |
| Rock Springs Capital Management LP | Reduced | 4,465,292 | -2,218,955 | 0.75% | $12,100,941 | 18 qtrs |
| 683 Capital Management LLC | Reduced | 4,350,000 | -285,000 | 0.77% | $11,788,499 | 11 qtrs |
| Clearline Capital LP | Added | 3,618,163 | +400,269 | 0.37% | $9,805,222 | 15 qtrs |
| The Goldman Sachs Group Inc This report | Added | 3,090,068 | +964,148 | < 0.01% | $8,374,084 | 15 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2025
- Filed
- August 14, 2025
- Filing type
- 13F-HR
- Position type
- CMN
Voting authority reported
- Sole
- 3,090,068
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.